Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Heart Journal

• Publication date

  2017-05-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/eurheartj/ehx011PMID 28329361PMCID PMC5837563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 17β‐Estradiol Protects Skeletal Myoblasts From Apoptosis Through p53, Bcl‐2, and FoxO Families

  2017cited by this paper
• Arrhythmogenic right ventricular cardiomyopathy: implications of next-generation sequencing in appropriate diagnosis

  2016cited by this paper
• Association of sex hormone-binding globulin and free testosterone with mortality in men with type 2 diabetes mellitus.

  2016cited by this paper
• Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls.

  2016cited by this paper
• Sex-dependent alterations of Ca2+ cycling in human cardiac hypertrophy and heart failure.

  2016cited by this paper
• Exercise and sex steroid hormones in skeletal muscle.

  2015cited by this paper
• Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers.

  2015cited by this paper
• Impact of atrial fibrillation on levels of high-sensitivity troponin I in a 75-year-old population

  2015cited by this paper
• Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy.

  2015cited by this paper
• In Vivo and In Vitro Evidences of Dehydroepiandrosterone Protective Role on the Cardiovascular System

  2015cited by this paper
• Testosterone modulates cardiac contraction and calcium homeostasis: cellular and molecular mechanisms

  2015cited by this paper
• Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia

  2015cited by this paper
• Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

  2015cited by this paper
• Estrogen and Cardiovascular Disease: Is Timing Everything?

  2015cited by this paper
• Association of Sex Hormones, Aging, and Atrial Fibrillation in Men: The Framingham Heart Study

  2014cited by this paper
• The Hippo Pathway Is Activated and Is a Causal Mechanism for Adipogenesis in Arrhythmogenic Cardiomyopathy

  2014cited by this paper
• Different Prognostic Value of Functional Right Ventricular Parameters in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

  2014cited by this paper
• Sex hormone levels in patients with sudden cardiac arrest.

  2014cited by this paper
• Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.

  2014cited by this paper
• Testosterone replacement increases aged pulmonary vein and left atrium arrhythmogenesis with enhanced adrenergic activity.

  2014cited by this paper
• Sex differences in cardiomyopathies

  2014cited by this paper
• Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy

  2014cited by this paper
• Testosterone and the Cardiovascular System: A Comprehensive Review of the Basic Science Literature

  2013cited by this paper
• Sex differences in mechanisms of cardiac excitation–contraction coupling

  2013cited by this paper
• Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy.

  2013cited by this paper
• Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.

  2013cited by this paper
• Compound and Digenic Heterozygosity Predicts Lifetime Arrhythmic Outcome and Sudden Cardiac Death in Desmosomal Gene–Related Arrhythmogenic Right Ventricular Cardiomyopathy

  2013cited by this paper
• Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs

  2012cited by this paper
• Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity.

  2011cited by this paper
• Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria

  2010cited by this paper
• Relationship between sex hormones and idiopathic outflow tract ventricular arrhythmias in adult male patients.

  2009cited by this paper
• A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy

  2009cited by this paper
• The aging male hypothalamic-pituitary-gonadal axis: pulsatility and feedback.

  2009cited by this paper
• Comparison of clinical features of arrhythmogenic right ventricular cardiomyopathy in men versus women.

  2008cited by this paper
• Sex and strain differences in adult mouse cardiac repolarization: importance of androgens.

  2005cited by this paper
• EX filter wire usage in stenting right coronary artery lesion with diffuse aneurysmal dilatation

  2004cited by this paper
• A critical evaluation of simple methods for the estimation of free testosterone in serum.

  1999cited by this paper
• Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.

  1997cited by this paper
• Evidence of apoptosis in arrhythmogenic right ventricular dysplasia.

  1996cited by this paper
• CLINICAL CASE*

  1930cited by this paper

• Generation of a PKP2 heterozygous knockout pig model of arrhythmogenic cardiomyopathy.

  2026cites this paper
• Sex Differences in Cardiomyopathies

  2026cites this paper
• Gender- and sex-dependent variations in heart failure and cardiomyopathies: a review of the literature.

  2026cites this paper
• Gene-Elusive Arrhythmogenic Cardiomyopathy: Roles of Sports, Inflammation and Beyond.

  2025cites this paper
• Statin effect on arrhythmogenic cardiomyopathy disease progression (SEARCH): Randomized clinical study protocol

  2025cites this paper
• Advances in arrhythmogenic cardiomyopathy modeling using hiPSC-based models.

  2025cites this paper
• Transmembrane Protein 43: Molecular and Pathogenetic Implications in Arrhythmogenic Cardiomyopathy and Various Other Diseases

  2025cites this paper
• Exercise in Inherited Cardiomyopathies: Optimizing the Dose-Response Curve.

  2025cites this paper
• Exploring Therapeutic Targets for Preventing Cardiac Arrest by Modulating Dyslipidemia and 25-Hydroxyvitamin D Metabolism: A Mendelian Randomization Study

  2025cites this paper
• New Insights in the Diagnostic Potential of Sex Hormone-Binding Globulin (SHBG)—Clinical Approach

  2025cites this paper
• Arrhythmic Risk Stratification in Patients with Arrhythmogenic Cardiomyopathy

  2025cites this paper
• Advances in Therapeutic Targets and Traditional Chinese Medicine for Cardiomyopathy

  2025cites this paper
• Deep phenotyping of testosterone-prompted fibrosis in arrhythmogenic right ventricular cardiomyopathy using iPSC-derived engineered cardiac spheroids

  2025cites this paper
• Desmoplakin Cardiomyopathy: Role of Inflammation and Potential Role of Disease-Modifying Therapies

  2025cites this paper
• Epigenetic Drugs Splitomicin, Suberohydroxamic Acid, CPTH6, BVT-948, and PBIT Moderate Fibro-Fatty Development in Arrhythmogenic Cardiomyopathy

  2025cites this paper
• Estrogen-sensitive menstrual cycle-dependent premature ventricular contractions successfully treated with combined contraceptive therapy: a case report

  2025cites this paper
• Structural Progression in Patients with Definite and Non-Definite Arrhythmogenic Right Ventricular Cardiomyopathy and Risk of Major Adverse Cardiac Events

  2024cites this paper
• Impaired Atrial and Ventricular Strain Predicts Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy.

  2024cites this paper
• Sex hormones and reproductive factors with cardiac arrhythmia and ECG indices: a mendelian randomization study

  2024cites this paper
• Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspects

  2024cites this paper
• Clinical features and outcomes in carriers of pathogenic desmoplakin variants

  2024cites this paper
• In Vivo Approaches to Understand Arrhythmogenic Cardiomyopathy: Perspectives on Animal Models

  2024cites this paper
• A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers

  2024cites this paper
• Characterization and Long-Term Prognosis of Patients with Different Phenotypes of Dilated Cardiomyopathy

  2024cites this paper
• Sex-Based Mechanisms of Cardiac Development and Function: Applications for Induced-Pluripotent Stem Cell Derived-Cardiomyocytes

  2024cites this paper
• Reduced plakoglobin increases the risk of sodium current defects and atrial conduction abnormalities in response to androgenic anabolic steroid abuse

  2024cites this paper
• Sex-based Differences in the Phenotypic Expression and Prognosis of Idiopathic Non-ischemic Cardiomyopathy: A Cardiovascular Magnetic Resonance Study.

  2024cites this paper
• Characterisation of patients referred to a tertiary-level inherited cardiac condition clinic with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC)

  2023cites this paper
• Management Strategies in Arrhythmogenic Cardiomyopathy across the Spectrum of Ventricular Involvement

  2023cites this paper
• Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy

  2023cites this paper
• Understanding Arrhythmogenic Cardiomyopathy: Advances through the Use of Human Pluripotent Stem Cell Models

  2023cites this paper
• Arrhythmogenic Cardiomyopathy: from Preclinical Models to Genotype–phenotype Correlation and Pathophysiology

  2023cites this paper
• Isolated JUP plakoglobin gene mutation with left ventricular fibrosis in familial arrhythmogenic right ventricular cardiomyopathy

  2023cites this paper
• 2023 ESC Guidelines for the management of cardiomyopathies.

  2023cites this paper
• Risk stratification of sudden cardiac death: a review

  2023cites this paper
• Sex Differences in Heart Failure: What Do We Know?

  2023cites this paper
• Prevention of Sudden Death and Management of Ventricular Arrhythmias in Arrhythmogenic Cardiomyopathy.

  2023cites this paper
• Trends in age and sex-specific dilated cardiomyopathy mortality in Italy, 2005–2017

  2023cites this paper
• The TMEM43 S358L mutation affects cardiac, small intestine, and metabolic homeostasis in a knock-in mouse model.

  2023cites this paper
• Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy

  2023cites this paper
• Sudden Death in Men Versus Women with Heart Failure

  2023cites this paper
• Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?

  2023cites this paper
• Sex Differences in Dilated Cardiomyopathy Prognosis.

  2022cites this paper
• Physical Exercise and Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An Overview

  2022cites this paper
• Acylation‐stimulating protein and heart failure progression in arrhythmogenic right ventricular cardiomyopathy

  2022cites this paper
• Menopause, androgens, and cardiovascular ageing: a narrative review

  2022cites this paper
• The Challenges of Diagnosis and Treatment of Arrhythmogenic Cardiomyopathy: Are We there yet?

  2022cites this paper
• Sex Differences in Cardiomyopathy

  2022cites this paper
• Sex Difference in Arrhythmic Risks and Prognosis in Patients with Nonischemic Cardiomyopathy: A Single-Center, Retrospective Study

  2022cites this paper
• Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?

  2022cites this paper
• Male sex hormone and reduced plakoglobin jointly impair atrial conduction and cardiac sodium currents

  2022cites this paper
• Right atrial strain and cardiovascular outcome in arrhythmogenic right ventricular cardiomyopathy.

  2022cites this paper
• Sex‐Related Differences in Genetic Cardiomyopathies

  2022cites this paper
• CLINICAL PROFILE AND LONG-TERM FOLLOW-UP OF A COHORT OF PATIENTS WITH DESMOPLAKIN CARDIOMYOPATHY.

  2022cites this paper
• Arrhythmogenic Right Ventricular Cardiomyopathy.

  2022cites this paper
• Validation of an Arrhythmogenic Right Ventricular Cardiomyopathy Risk-Prediction Model in a Chinese Cohort

  2022cites this paper
• Predictors of left atrial fibrosis in patients with atrial fibrillation referred for catheter ablation

  2022cites this paper
• Long-Term Electrocardiographic and Echocardiographic Progression of Arrhythmogenic Right Ventricular Cardiomyopathy and Their Correlation With Ventricular Tachyarrhythmias

  2021cites this paper
• Testosterone, cardiomyopathies, and heart failure: a narrative review

  2021cites this paper
• Sex Differences in Right Ventricular Dysfunction: Insights From the Bench to Bedside

  2021influential citation
• The Link Between Sex Hormones and Susceptibility to Cardiac Arrhythmias: From Molecular Basis to Clinical Implications

  2021cites this paper
• Gender-affirming hormone treatment causes changes of gender phenotype in a 12-lead electrocardiogram.

  2021cites this paper
• Genetic Cardiomyopathies: The Lesson Learned from hiPSCs

  2021cites this paper
• Crosstalk between coagulation and complement activation promotes cardiac dysfunction in arrhythmogenic right ventricular cardiomyopathy

  2021cites this paper
• Sex differences in disease progression and arrhythmic risk in patients with arrhythmogenic cardiomyopathy

  2021cites this paper
• Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy

  2021cites this paper
• Higher 1-year mortality in women admitted to intensive care units after cardiac arrest: A nationwide overview from the Netherlands between 2010 and 2018.

  2021cites this paper
• Arrhythmogenic Cardiomyopathy—Current Treatment and Future Options

  2021cites this paper
• Generation and characterization of three human induced pluripotent stem cell lines (EURACi007-A, EURACi008-A, EURACi009-A) from three different individuals of the same family with arrhythmogenic cardiomyopathy (ACM) carrying the plakophillin2 p.N346Lfs*12 mutation.

  2021cites this paper
• Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure

  2021cites this paper
• Preclinical short QT syndrome models: studying the phenotype and drug-screening.

  2021cites this paper
• Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy

  2021cites this paper
• Novel Plasma Biomarkers Predicting Biventricular Involvement in Arrhythmogenic Right Ventricular Cardiomyopathy: Novel Biomarkers in ARVC.

  2021cites this paper
• Ventricular Arrhythmias

  2021cites this paper
• MicroRNAs: From Junk RNA to Life Regulators and Their Role in Cardiovascular Disease

  2021cites this paper
• Histopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy

  2021cites this paper
• Ventricular arrhythmia management in patients with genetic cardiomyopathies

  2021cites this paper
• Arrhythmogenic right ventricular cardiomyopathy: diverse substrate characteristics and ablation outcome.

  2021cites this paper
• Risk of sports-related sudden cardiac death in women.

  2021cites this paper
• Clinical characteristics and determinants of phenotype in TMEM43 Arrhythmogenic right ventricular cardiomyopathy type 5.

  2020cites this paper
• Elevated plasma β-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy

  2020cites this paper
• Induced Pluripotent Stem Cells

  2020cites this paper
• Sex-Specific Differences of Apoptosis in Heart Failure Due to Volume-Overload

  2020cites this paper
• Familial Arrhythmogenic Cardiomyopathy: Clinical Determinants of Phenotype Discordance and the Impact of Endurance Sports

  2020cites this paper
• Arrhythmias right ventricular cardiomyopathy and sports activity: from molecular pathways in diseased hearts to new insights into the athletic heart mimicry.

  2020cites this paper
• Persistent Troponin Elevation in Left-Dominant Arrhythmogenic Cardiomyopathy.

  2020cites this paper
• Dilated cardiomyopathy

  2020cites this paper
• Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models

  2020cites this paper
• New Insights in RBM20 Cardiomyopathy

  2020cites this paper
• Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients.

  2020cites this paper
• Sudden cardiac death in the young: gender differences

  2020cites this paper
• Arrhythmogenic Cardiomyopathy: Molecular Insights for Improved Therapeutic Design

  2020cites this paper
• Plasma testosterone and arrhythmic events in male patients with arrhythmogenic right ventricular cardiomyopathy

  2020influential citation
• Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutation.

  2020cites this paper
• Familial Recurrent Myocarditis Triggered by Exercise in Patients With a Truncating Variant of the Desmoplakin Gene

  2020cites this paper
• Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy

  2020cites this paper
• Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue

  2020cites this paper
• Dual-Organ Transplantation in a Woman With Right Ventricular Failure Secondary to Arrhythmogenic Right Ventricular Cardiomyopathy

  2020influential citation
• Uncovering sex-specific mechanisms of action of testosterone and redox balance

  2020cites this paper
• Arrhythmogenic right ventricular cardiomyopathy

  2019cites this paper